Sulfonamides as multifunctional agents for Alzheimer's disease. 2015

Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
Department of Chemistry, University of Massachusetts Boston, 100 Morrissey Blvd., Boston, MA, USA.

Sulfonamide linker-based inhibitors with extended linear structure were designed and synthesized with the aim of producing multifunctional agents against several processes involved in the pathology of Alzheimer's disease (AD). The potency of the compounds were assessed in the inhibition of Aβ self-assembly (fibril and oligomer formation), in modulating cholinesterase (AChE, BuChE) activity, and scavenging free radicals. Several compounds exhibited promising Aβ self-assembly and cholinesterase inhibition and in parallel, showed good free radical scavenging properties. The investigation of the scaffold described in this study resulted in the identification of three compounds (14, 19 and 26) as promising leads for the further design of multifunctional drug candidates for AD.

UI MeSH Term Description Entries
D007189 Indans Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES. Indanones
D010880 Piperidines A family of hexahydropyridines.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002091 Butyrylcholinesterase An aspect of cholinesterase (EC 3.1.1.8). Pseudocholinesterase,Benzoylcholinesterase,Butyrylthiocholinesterase
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077265 Donepezil An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE. 1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride,Aricept,Donepezil Hydrochloride,Donepezilium Oxalate Trihydrate,E 2020,E-2020,E2020,Eranz
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
December 2019, Future medicinal chemistry,
Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
August 2015, Bioorganic & medicinal chemistry,
Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
May 2016, Molecules (Basel, Switzerland),
Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
October 2021, Molecules (Basel, Switzerland),
Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
December 2011, Bioorganic & medicinal chemistry,
Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
September 2019, European journal of medicinal chemistry,
Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
January 2022, Frontiers in chemistry,
Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
June 2017, Bioorganic chemistry,
Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
January 2019, International journal of molecular sciences,
Seema Bag, and Rekha Tulsan, and Abha Sood, and Hyejin Cho, and Hana Redjeb, and Weihong Zhou, and Harry LeVine, and Béla Török, and Marianna Török
September 2019, Bioorganic chemistry,
Copied contents to your clipboard!